Our profession faces one of the most significant crises in its history,” said Michael Graham, M.D., president of ...
Nuclear Imaging
Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
Feature | Stephanie LaBelle, senior analyst, Millennium Research Group
In recent years, the U.S. cardiac device market has focused on dynamics in the drug-eluting stent (DES) segment – ...
November 18, 2009
November 13, 2009 – A new imaging agent for measuring and monitoring cathepsin B activity associated with disease ...
November 13, 2009
November 12, 2009 - Positron Corp. predicts an industry wide demand for cardiac PET imaging, as a result of the ...
November 12, 2009November 6, 2009 - As the American Medical Isotopes Production Act of 2009 now heads to the U.S. Senate for ...
November 06, 2009November 4, 2009 - The Centers for Medicare and Medicaid Services (CMS) released the review copy of the 2010 ...
November 04, 2009
November 3, 2009 – By relying solely on a patient’s clinical risk profile or the results of one imaging test when ...
November 03, 2009October 28, 2009 - The imaging industry, especially the new molecular technologies, will drive personalized ...
October 26, 2009
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete ...
October 21, 2009
October 11, 2009 – GE Healthcare announced the European launch of Discovery NM/CT 670, a hybrid imaging platform ...
October 12, 2009
October 6, 2009 – Siemens Healthcare announced the availability of syngo Dynamic PET with myocardial blood flow, a ...
October 06, 2009
September 30, 2009 – Positron Corp. predicts a significant rise in demand for cardiac PET in 2010 with a proposed ...
September 29, 2009
September 29, 2009 - Positron Corp., a molecular imaging solutions company focused on nuclear cardiology, will ...
September 29, 2009
September 21, 2009 – IBA (Ion Beam Applications S.A.), a provider of PET radiopharmaceuticals, and Aposense Ltd ...
September 21, 2009
Feature | Dave Fornell
Ruptured vulnerable plaque (VP) is blamed for the majority of acute myocardial infarctions and many strokes, but ...
September 17, 2009